PH12020551635A1 - Enteric coated tablet comprising fenofibric acid or pharmaceutically acceptable salt thereof - Google Patents

Enteric coated tablet comprising fenofibric acid or pharmaceutically acceptable salt thereof

Info

Publication number
PH12020551635A1
PH12020551635A1 PH12020551635A PH12020551635A PH12020551635A1 PH 12020551635 A1 PH12020551635 A1 PH 12020551635A1 PH 12020551635 A PH12020551635 A PH 12020551635A PH 12020551635 A PH12020551635 A PH 12020551635A PH 12020551635 A1 PH12020551635 A1 PH 12020551635A1
Authority
PH
Philippines
Prior art keywords
pharmaceutically acceptable
acceptable salt
coated tablet
enteric coated
fenofibric acid
Prior art date
Application number
PH12020551635A
Inventor
Youn Woong Choi
Sang Min Cho
Do Hyoung Ki
In Ho Song
Original Assignee
Korea United Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea United Pharm Inc filed Critical Korea United Pharm Inc
Publication of PH12020551635A1 publication Critical patent/PH12020551635A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to an enteric coated tablet comprising fenofibric acid or a pharmaceutically acceptable salt thereof and to a manufacturing method therefor. The present invention can minimize the loss of a drug and increase the solubility of the drug, thereby maximizing bioavailability with even a small amount of the drug.
PH12020551635A 2018-04-24 2020-10-01 Enteric coated tablet comprising fenofibric acid or pharmaceutically acceptable salt thereof PH12020551635A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180047078A KR102081095B1 (en) 2018-04-24 2018-04-24 Enteric coated formulation comprising fenofibric acid a or pharmaceutically acceptable salts thereof
PCT/KR2019/004601 WO2019208967A1 (en) 2018-04-24 2019-04-16 Enteric coated tablet comprising fenofibric acid or pharmaceutically acceptable salt thereof

Publications (1)

Publication Number Publication Date
PH12020551635A1 true PH12020551635A1 (en) 2021-07-26

Family

ID=68295511

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12020551635A PH12020551635A1 (en) 2018-04-24 2020-10-01 Enteric coated tablet comprising fenofibric acid or pharmaceutically acceptable salt thereof

Country Status (3)

Country Link
KR (1) KR102081095B1 (en)
PH (1) PH12020551635A1 (en)
WO (1) WO2019208967A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112603899A (en) * 2020-12-23 2021-04-06 南京友杰医药科技有限公司 Rebamipide enteric-coated tablet and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224058A1 (en) * 2002-05-24 2003-12-04 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
WO2006084475A2 (en) * 2005-04-13 2006-08-17 Lifecycle Pharma A/S A tablet comprising a fibrate
KR101202994B1 (en) * 2010-04-12 2012-11-21 한미사이언스 주식회사 Oral pharmaceutical composition comprising fenofibric acid and an alkalifying agent
KR101925590B1 (en) * 2016-08-30 2018-12-05 대원제약 주식회사 Formulation of fenofibric acid with improved bioavailability

Also Published As

Publication number Publication date
WO2019208967A1 (en) 2019-10-31
KR102081095B1 (en) 2020-02-25
KR20190123411A (en) 2019-11-01

Similar Documents

Publication Publication Date Title
MX2020003629A (en) Fermentative production of n-acetylneuraminic acid.
EP3912166C0 (en) Medication tracking system
MX2020007554A (en) Pharmaceutical formulation comprising esomeprazole and sodium bicarbonate.
EP3378434A4 (en) Method for the production of a dental structure, produced dental structure and dental assembly formed by a structure screwed onto a dental implant
EP4076003A4 (en) Method of increasing the productivity of a non-ruminant animal
ZA202107709B (en) Cell-free production of ribonucleic acid
PH12018501356A1 (en) Cocrystal, production method tereof, and medicament containing cocrystal
MY189306A (en) Tablet
EP4058371A4 (en) Labeling shell for a drug vial
PH12020551635A1 (en) Enteric coated tablet comprising fenofibric acid or pharmaceutically acceptable salt thereof
IN2013MU01985A (en)
IL289520A (en) Method for stabilizing the ph of an aqueous composition comprising a drug
EP3728280C0 (en) Method for improving the oral bioavailability of a drug
EP3885333A4 (en) Production method of 1,2-difluoroethylene
EP3689349A4 (en) Drug containing pyridylaminoacetic acid compound
EP4069214A4 (en) Polyphosphazene drug carriers
EP3962460A4 (en) Method for the production of pullulan capsules
ZA202000381B (en) Process for making esters of 2,5-furandicarboxylic acid
WO2020018053A3 (en) The tablet comprising dasatinib
WO2018229796A3 (en) A process for the preparation of betrixaban hydrochloride
EP3733243A4 (en) Drug administration method
UA124942C2 (en) Process for the preparation of pirlindole enantiomers and its salts
MX2017015888A (en) Preparation of 2,5,6-trihydroxy-3-hexenoic acid and 2,5-dihydroxy-3-pentenoic acid and esters thereof from c6 and c5 sugars.
GB201722224D0 (en) Aspirin drug intermediate high purity acetic acid production plant
EP3843712A4 (en) Process for manufacturing pibrentasvir active drug substance